Linezolid susceptibility in MRSA isolates: insights into resistance and concordance in phenotypic detection methods
DOI:
https://doi.org/10.18203/2320-6012.ijrms20240220Keywords:
Linezolid, Linezolid resistant MRSA, Minimum inhibitory concentration, MRSAAbstract
Background: Methicillin-resistant staphylococcus aureus (MRSA) poses persistent threat, affecting both healthcare environment and communities, with substantial impact on infection rates, morbidity, mortality, and healthcare costs. Vancomycin, a longstanding cornerstone in MRSA treatment, but with the emergence of vancomycin resistant MRSA (VRSA), necessitating alternative antimicrobial solutions. Linezolid, stands out as a promising candidate. It has unique advantages such as an absence of renal toxicity and improved lung parenchymal diffusion compared to vancomycin, making it an appealing choice, especially for healthcare-acquired pneumonia by MRSA.
Methods: This cross-sectional study investigated linezolid susceptibility in 158 MRSA isolates using both disk diffusion and agar dilution method.
Results: Results indicated that the majority of isolates exhibited linezolid susceptibility, with 53.16% showing a minimum inhibitory concentration (MIC) of ≤2 µg/ml. However, two MRSA isolates, constituting 1.27% of the sample, displayed a MIC of 8 µg/ml, named them as a linezolid-resistant MRSA (LRSA). These findings align with previous research, mirroring resistance rates observed in different regions. Notably, vigilance against linezolid resistance is crucial, particularly due to its status as a last-resort MRSA treatment.
Conclusions: Remarkably, a 100% concordance was found between the disk diffusion and MIC methods for detecting linezolid resistance in MRSA, suggesting that the disk diffusion method may be practical choice for laboratories with heavy workloads. However, adherence to CLSI guidelines is essential, and cases of resistance by disk diffusion should be confirmed using MIC methods. Emergence of linezolid-resistant MRSA is a worrisome development, necessitating ongoing surveillance and vigilance.
References
Harkins CP, Pichon B, Doumith M, Parkhill J, Westh H, Tomasz A, et al. Methicillin-resistant Staphylococcus aureus emerged long before the introduction of methicillin into clinical practice. Genome biol. 2017;18(1):1-11.
Mamtora D, Saseedharan S, Bhalekar P, Katakdhond S. Microbiological profile and antibiotic susceptibility pattern of Gram-positive isolates at a tertiary care hospital. J Lab Phys. 2019;11(02):144-8.
Choo EJ, Chambers HF. Treatment of methicillin-resistant Staphylococcus aureus bacteremia. Infect Chemother. 2016;48(4):267-73.
Tsiodras S, Gold HS, Sakoulas G, Eliopoulos GM, Wennersten C, Venkataraman L, et al. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet. 2001;358(9277):207-8.
Watanabe S, Kawakami Y, Kimura H, Murakami S, Miyamoto H, Takatori S, et al. Association between daptomycin susceptibility and teicoplanin resistance in Staphylococcus epidermidis. Sci Rep. 2019;9(1):1-5
Morales G, Picazo JJ, Baos E, Candel FJ, Arribi A, Peláez B, et al. Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus. Clin Infect Dis. 2010;50(6):821-5.
Locke JB, Hilgers M, Shaw KJ. Novel ribosomal mutations in Staphylococcus aureus strains identified through selection with the oxazolidinones linezolid and torezolid (TR-700). Antimicrob Agents Chemother. 2009;53:5265-74
Rouard C, Garnier F, Leraut J, Lepainteur M, Rahajamananav L, Languepin J, et al. Emergence and within-host genetic evolution of methicillin-resistant Staphylococcus aureus resistant to linezolid in a cystic fibrosis patient. Antimicrob Agents Chemother. 2018;62(12): e00720-18.
CLSI. Performance standards for antimicrobial susceptibility testing; 30th edn. Informational supplement M100. Wayne, PA: Clinical Laboratory Standards Institute; 2020.
US Department of Health and Human Services. Antibiotic resistance threats in the United States, 2013. Centers for disease control and prevention. 2013:1-13.
Thomson RB, Miller JM. Specimen collection, transport, and processing: bacteriology. Manual of clinical microbiology, 8th ed. American Society for Microbiology, Washington, DC; 2003;286-330.
Baird D. Staphylococci: cluster forming gram positive cocci. In: Collee JG, Fraser AG, Marmion BP, Simmons A, eds. Mackie and Mc Cartney, Practical Medical Microbiology. 14th edn. New York: Churchil Livingstone; 1996:245-261.
Hashemian SM, Farhadi T, Ganjparvar M. Linezolid: a review of its properties, function, and use in critical care. Drug Design Develop Ther. 2018:1759-67.
Khanam S, Haq JA, Shamsuzzaman SM, Rahman MM, Mamun KZ. Emergence of vancomycin resistant Staphylococcus aureus during hospital admission at a tertiary care hospital in Bangladesh. Bangladesh J Infect Dis. 2016;3(1):11-6.
Wali M, Shah MS, Rehman TU, Wali H, Hussain M, Zaman L, et al. Detection of linezolid resistance cfr gene among MRSA isolates. J Infect Public Health. 2022;15(10):1142-6.
Singh H, Atray M, Modi PK. Antibiotic susceptibility pattern of methicillin resistance Staphylococcus aureus in tertiary care center at southern Rajasthan. Int J Pharm Sci Res. 2014;5(2):607-11.
Mandal M, Dey S, Kumar D, Biswas PP, Nandan K, Sen A. Determination of vancomycin and linezolid resistance in Staphylococcus aureus isolated from Katihar district of Bihar, India. J Evol Med Dent Sci. 2017;6(16):1244-8.
Hussain J, Thakur A, Mishra B, Dogra V, Jaggi T. Antimicrobial susceptibility pattern of methicillin-resistant strains of Staphylococcus aureus in a super specialty hospital. Int J Health Allied Sci. 2015;4(2):69-72.
Xu Y, Wang B, Zhao H, Wang X, Rao L, Ai W, et al. In vitro activity of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant Staphylococcus aureus isolates collected from Chinese hospitals in 2018-2020. Infect Drug Resist. 2021;14:5449-56.
Sharlee R, Sumangala B. A study to comparison of MIC of linezolid on MRSA by micro broth dilution and e strip method in teaching hospital, Karnataka, India. Int J Curr Microbiol App Sci. 2020;9(03):2848-56.
Heyar AK, Gill AK, Mahajan A, Kaur K. Prevalence and antibiotic sensitivity pattern of Staphylococcus aureus from all clinical samples with emphasis on MRSA in a tertiary care hospital. J Evol Med Dent Sci. 2017;6(84):5857-60.
Kakhandki LS, Parandekar BP. Detection of in-vitro activity of linezolid in methicillin resistant Staphylococcus aureus infections by E-test. JKIMSU. 2012;1(2):72-5.
Thool VU, Bhoosreddy GL, Wadher BJ. Detection of resistance to linezolid in Staphylococcus aureus infecting orthopedic patients. Indian J Pathol Microbiol. 2012;55(3):361-4.
Azhar A, Rasool S, Haque A, Shan S, Saeed M, Ehsan B, et al. A. Detection of high levels of resistance to linezolid and vancomycin in Staphylococcus aureus. J Med Microbiol. 2017;66(9):1328-31.
Kaur DC, Chate SS. Study of antibiotic resistance pattern in methicillin resistant Staphylococcus aureus with special reference to newer antibiotic. J Glob Infect Dis. 2015;7(2):78-84.
Kot B, Piechota M, Jakubczak A, Gryzińska M, Witeska M, Grużewska A, et al. The prevalence of virulence determinants in methicillin-resistant Staphylococcus aureus isolated from different infections in hospitalized patients in Poland. Sci Rep. 2022;12(1):1-11.
Barrett JF. MRSA: status and prospects for therapy? An evaluation of key papers on the topic of MRSA and antibiotic resistance. Exp Opin Therap Targets. 2004;8(6):515-9.
